Related references
Note: Only part of the references are listed.Incidence of Adenovirus Infection in Hematopoietic Stem Cell Transplantation Recipients: Findings from the AdVance Study
Petr Sedlacek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Tiziana Lazzarotto et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?
Carlos Solano et al.
BONE MARROW TRANSPLANTATION (2018)
Multicenter phase 1/2 application of adenovirus-specific T cells in high-risk pediatric patients after allogeneic stem cell transplantation
Winnie Ip et al.
CYTOTHERAPY (2018)
The impact of alternative donor types on viral infections in pediatric hematopoietic stem cell transplantation
D. Atay et al.
PEDIATRIC TRANSPLANTATION (2018)
Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT
C. Qian et al.
BONE MARROW TRANSPLANTATION (2018)
Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant
Prashant Hiwarkar et al.
BLOOD (2017)
Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation
Evelyn Rustia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Immune recovery and the risk of CMV/EB reactivation in children post allogeneic haematopoietic stem cell transplantation
Malgorzata Janeczko et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines
Jan Styczynski et al.
HAEMATOLOGICA (2016)
HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns
Adrien Quintela et al.
JOURNAL OF INFECTION (2016)
Cytomegalovirus-Specific T Cells Isolated by IFN-γ Secretion Assay Do Not Induce Significant Graft-Versus-Host Reactions In Vitro
Marsela Qesari et al.
TRANSPLANTATION (2016)
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines
Jan Styczynski et al.
HAEMATOLOGICA (2016)
Recent Advances in Cytomegalovirus: An Update on Pharmacologic and Cellular Therapies
Michael Boeckh et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Impact of Serotherapy on Immune Reconstitution and Survival Outcomes After Stem Cell Transplantations in Children: Thymoglobulin Versus Alemtuzumab
Laura Willemsen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia
Guenther Koehne et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT
Judith Feucht et al.
BLOOD (2015)
Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation
Chun K. K. Ma et al.
CYTOTHERAPY (2015)
Oral Valganciclovir as Preemptive Therapy for Cytomegalovirus Reactivation in Pediatric Hematopoietic Stem Cell Transplant Patients
Didem Atay et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2015)
Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients
Borae G. Park et al.
LEUKEMIA RESEARCH (2015)
Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome
Caroline A. Lindemans et al.
BLOOD (2014)
EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT
L. Rasche et al.
BONE MARROW TRANSPLANTATION (2014)
Adenovirus Infections in Immunocompetent and Immunocompromised Patients
Thomas Lion
CLINICAL MICROBIOLOGY REVIEWS (2014)
Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation
Jiju Mani et al.
CYTOTHERAPY (2014)
Therapeutic strategies for cytomegalovirus infection in haematopoietic transplant recipients: a focused update
Rob S. Sellar et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT
Anastasia Papadopoulou et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation
Emily Blyth et al.
BLOOD (2013)
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
Ann M. Leen et al.
BLOOD (2013)
Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients
P. Hiwarkar et al.
BONE MARROW TRANSPLANTATION (2013)
Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1-Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
Vanya Icheva et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
Ekaterina Doubrovina et al.
BLOOD (2012)
Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant
Uluhan Sili et al.
CYTOTHERAPY (2012)
European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011)
S. Matthes-Martin et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Improving Safety of Preemptive Therapy with Oral Valganciclovir for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
Corinna Barkam et al.
BONE MARROW RESEARCH (2012)
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient
A. Balduzzi et al.
BONE MARROW TRANSPLANTATION (2011)
Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease
Waseem Qasim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation
Karl S. Peggs et al.
CLINICAL INFECTIOUS DISEASES (2011)
Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation
Patrick J. Hanley et al.
CYTOTHERAPY (2011)
Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001
Kris Paolino et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
BK Virus-Specific T Cells for Use in Cellular Therapy Show Specificity to Multiple Antigens and Polyfunctional Cytokine Responses
Emily Blyth et al.
TRANSPLANTATION (2011)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
Tobias Feuchtinger et al.
BLOOD (2010)
A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation
Michael Uhlin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy
B. George et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
Ann M. Leen et al.
BLOOD (2009)
The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor
Phillip Scheinberg et al.
BLOOD (2009)
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque et al.
BLOOD (2007)
Outcome of hematopoietic stem cell transplantation in severe combined immune deficiency with central nervous system viral infection
Cathy Waruiru et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention
Ponni Sivaprakasain et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2007)
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
Ann M. Leen et al.
NATURE MEDICINE (2006)
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation
K Perruccio et al.
BLOOD (2005)
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers
M Cobbold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Adenovirus infection after pediatric bone marrow transplantation: Is treatment always necessary?
T Walls et al.
CLINICAL INFECTIOUS DISEASES (2005)
Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines
KS Peggs et al.
LANCET (2003)
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy
H Einsele et al.
BLOOD (2002)
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs
S Gottschalk et al.
BLOOD (2001)
Depletion of alloreactive donor T cells using immunomagnetic cell selection
B Fehse et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
